Sign in
8-K

Current Report

Cocrystal Pharma, Inc. Filed Acc 0001415889-14-003751

Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 3.02 Unregistered sales of equity securities
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading cocp8k_nov25.htm…